Xenopsin 2TFA(51827-01-1(free base)
CAS No. ——
Xenopsin 2TFA(51827-01-1(free base) ( —— )
产品货号. M22780 CAS No. ——
Xenopsin(2TFA) is a neurotensin-like octapeptidepreviously isolated from amphibian skin.The octapeptide xenopsin, previously isolated from amphibian skin, stimulates exocrine pancreatic secretion of bicarbonate and protein in conscious dogs and increases the volume of secretion.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥1013 | 有现货 |
|
5MG | ¥1447 | 有现货 |
|
10MG | ¥2417 | 有现货 |
|
25MG | ¥4468 | 有现货 |
|
50MG | ¥6847 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Xenopsin 2TFA(51827-01-1(free base)
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Xenopsin(2TFA) is a neurotensin-like octapeptidepreviously isolated from amphibian skin.The octapeptide xenopsin, previously isolated from amphibian skin, stimulates exocrine pancreatic secretion of bicarbonate and protein in conscious dogs and increases the volume of secretion.
-
产品描述Xenopsin(2TFA) is a neurotensin-like octapeptidepreviously isolated from amphibian skin.The octapeptide xenopsin, previously isolated from amphibian skin, stimulates exocrine pancreatic secretion of bicarbonate and protein in conscious dogs and increases the volume of secretion.This effect is shown in the dose range of 1.25 up to 160 pmoles kg 1 min 1 The high potency of this peptide is suggestive of a possible physiological role of xenopsin in mammals.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number——
-
分子量980.16
-
分子式C47H73N13O10
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(C)C)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Feurle G E , I Baa, Knauf W , et al. Xenopsin stimulates exocrine pancreatic secretion in the dog[J]. Experientia, 1982, 38(6):679-680.